Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma

Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma

Introduction Dry mouth is the main symptom of sicca syndrome, which rarely occurs as an immune‐related adverse event. Here we report a case of sicca syndrome caused by immune checkpoint inhibitor treatment. Case presentation A 70‐year‐old man was diagnosed with left renal cell carcinoma after radica...

Full description

Bibliographic Details
Main Authors: Takuya Segawa, Takanobu Motoshima, Junji Yatsuda, Ryoma Kurahashi, Yumi Fukushima, Yoji Murakami, Takahiro Yamaguchi, Yutaka Sugiyama, Ryoji Yoshida, Hideki Nakayama, Tomomi Kamba
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:IJU Case Reports
Subjects:
immune checkpoint inhibitor
immune‐related adverse event
pilocarpine
sicca syndrome
xerostomia
Online Access:https://doi.org/10.1002/iju5.12573

Internet

https://doi.org/10.1002/iju5.12573

Similar Items